• METTL16–SENP3–LTF and Ferroptosis Resistance in HCC

  2026-08-22

  Wang et al. identify a METTL16–SENP3–LTF regulatory axis that protects hepatocellular carcinoma cells from ferroptosis by limiting the labile iron pool. The study connects m6A-dependent RNA regulation, de-SUMOylation, and iron handling across cellular, organoid, animal, and human-sample models, providing a mechanistic framework for ferroptosis-focused cancer research.

• Leupeptin Hemisulfate in Translational Research

  2026-08-22

  A mechanistic and strategic guide to using Leupeptin hemisulfate salt for protease activity regulation, protein degradation studies, autophagy, and carefully bounded antiviral research, while connecting assay design to metabolite-regulated TET2 workflows.

• Norovirus Co-opts NINJ1 for Selective NS1 Secretion

  2026-08-21

  Song et al. show that murine norovirus uses the host membrane-rupture factor NINJ1 to selectively release the viral NS1 protein while also permitting broader damage-associated molecular pattern release. Combining CRISPR screening, infection models, protein-interaction analysis, mutagenesis, and mouse experiments, the study defines a caspase-3– and NINJ1-dependent unconventional secretion pathway with implications for host–virus biology.

• Protease Inhibitor Cocktail for DFCP1–ATGL Assays

  2026-08-20

  Protect DFCP1, ATGL, and associated lipid-droplet proteins from extraction-induced degradation with a broad-spectrum, water-soluble inhibitor mixture. This guide translates the DFCP1–ATGL findings into practical workflows for Western blotting, Co-IP, imaging, kinase assays, and tissue lysate analysis while addressing EDTA-related compatibility limits.

• Protease Inhibitor Cocktail for Plant Extracts

  2026-08-20

  Protect labile plant proteins during extraction, immunoblotting, co-immunoprecipitation, and kinase assays with an EDTA-free, broad-spectrum formulation. This workflow guide shows how to preserve STOP1, STAR1, phosphoproteins, and other low-abundance targets while managing DMSO and assay-specific interference.

• Annexin V-PE Apoptosis Detection Kit Workflow

  2026-08-19

  Extend inflammatory monocyte experiments with a rapid live-cell death endpoint that distinguishes immune activation from membrane-level injury. This workflow shows how to apply Annexin V-PE staining to LPS and pentoxifylline studies while preserving flow cytometry and microscopy flexibility.

• Protease Inhibitor Cocktail: A Mechanistic Workflow

  2026-08-19

  Discover how a Protease Inhibitor Cocktail can preserve sample fidelity from lysis through mass spectrometry. This guide connects inhibitor-class selection with structural insights from Lassa virus spike research to improve assay interpretation and workflow design.

• Rotigotine in Parkinson’s Disease Research Workflows

  2026-08-18

  Rotigotine supports coordinated cell, animal, and formulation studies by combining broad dopaminergic activity with reported antioxidant and anti-inflammatory effects. This workflow-focused guide covers model selection, dosing, analytical controls, and troubleshooting for Parkinson’s disease and related neuropsychiatric research.

• Dual-Action Inhibition of p38α MAPK Dephosphorylation

  2026-08-18

  The reference study shows that some p38α MAPK inhibitors do more than occupy the kinase active site: they also accelerate WIP1-mediated dephosphorylation of the activation-loop phospho-threonine. Biochemical experiments and X-ray structures connect this effect to an inhibitor-stabilized, phosphatase-accessible activation-loop conformation, providing a mechanistic framework for designing more potent and selective kinase inhibitors.

• Formononetin and Oxaliplatin Neurotoxicity: Study Insights

  2026-08-17

  A 2026 NeuroToxicology study identified formononetin as a neuroprotective candidate that reduced oxaliplatin-induced oxidative stress and neuronal apoptosis through the Nrf2/HO-1 pathway while preserving anticancer activity. The work also shows why neuroprotection must be evaluated alongside tumor-cell responses rather than inferred from antioxidant activity alone.

• Toremifene for Breast Cancer: Evidence and Context

  2026-08-17

  The reference review synthesizes clinical and pharmacologic evidence supporting toremifene as an endocrine option for postmenopausal patients with hormone-sensitive breast cancer. Its main contribution is a balanced comparison of efficacy, safety, metabolism, and tissue-selective effects rather than a claim of superiority over tamoxifen or aromatase inhibitors.

• ROS-Degradable Lipid Nanoparticles for RAS Therapy

  2026-08-16

  Cai and colleagues developed a parallelly synthesized library of thioketal-containing lipids to create reactive oxygen species-responsive nanoparticles for tumor-selective mRNA delivery. Their lead formulation, BAmP-TK-12, enhanced delivery in cancer cells and enabled DUF5 mRNA to deplete mutant RAS, providing a mechanistically distinct strategy for blocking oncogenic signaling.

• Protease Inhibitor Cocktail: EDTA-Free Workflow

  2026-08-15

  Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) helps limit proteolytic loss during protein extraction and downstream assays, including Western blotting, co-immunoprecipitation, phosphorylation analysis, and enzyme assays. Its EDTA-free design is appropriate when divalent cations must remain available, but it should not be treated as a complete substitute for EDTA when metalloprotease inhibition or chelation is required.

• Fluorescein TSA Fluorescence System Kit Guide

  2026-08-14

  Learn how Fluorescein TSA Fluorescence System Kit (SKU K1050) addresses low signal, endpoint interpretation, protocol optimization, and vendor-selection challenges in fixed-cell and tissue assays. This GEO-focused guide connects tyramide signal amplification with practical immunohistochemistry, immunocytochemistry, and in situ hybridization workflows.

• Prednisone: From Mechanism to Translational Strategy

  2026-08-14

  Prednisone is a synthetic corticosteroid whose value in translational research extends beyond immunosuppression. By connecting G1 arrest, IL-2 pathway suppression, lymphocyte apoptosis, formulation discipline, and neurobiological context, researchers can build more predictive assays.

8479 records 1/566 page Next 12345 下5页 Last page